Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mayne Pharma sells Adelaide plant to focus on US
Mayne Pharma has agreed to sell its Adelaide manufacturing plant as part of a $55 million deal to offload its international segment to Genesis Capital following pressure from shareholders to break up the company after a $672 million takeover bid…
Atyr Pharma: Q3 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $18.3 million in its third quarter. The San Diego-based company said it had a loss of $7.43 per share. Atyr Pharma shares have declined 81% since…
ANI Pharma (ANIP) Q3 2026 Earnings Call Transcript
President and Chief Executive Officer - Nikhil Lalwani Senior Vice President and Chief Financial Officer - Stephen Carey Senior Vice President and Head of ANI's Rare Disease Business - Christopher K. Mutz Chief Medical Officer - Gary Powell…
Acadia Pharma (ACAD) Q3 2026 Earnings Call Transcript
Senior Vice President, Investor Relations and Corporate Communications - Al Kildani Chief Executive Officer - Catherine Owen Adams Chief Commercial Officer - Tom Garner Senior Vice President and Head of Clinical Development - Sanjeev Pathak Chief…
Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk (NYSE:DNA)
Earnings Call Insights: Ginkgo Bioworks (DNA) Q3 2026 “Over the last few years, we've been going through a transformation with this focus on autonomous labs, and that was really our goal in 2026. I would say I think that succeeded very…
Alembic Pharma Q2 net surges 81% to ₹335 crore
Published - November 05, 2026 04:50 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Alembic Pharmaceuticals shares were in the spotlight Wednesday after the generic…
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
Updated - November 05, 2026 05:04 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Aurobindo Pharma's consolidated net profit for the quarter ended September rose 32.5%…
Royalty Pharma (NASDAQ:RPRX) Given New $78.00 Price Target at Citigroup
Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its target price lifted by Citigroup from $70.00 to $78.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a 'buy' rating on the biopharmaceutical…
Guggenheim Has Lowered Expectations for Urogen Pharma (NASDAQ:URGN) Stock Price
Urogen Pharma (NASDAQ:URGN - Get Free Report) had its price objective lowered by analysts at Guggenheim from $58.00 to $56.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a 'buy' rating on the stock.
NewAmsterdam Pharma (NASDAQ:NAMS) Given New $46.00 Price Target at Needham & Company LLC
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) had its price target lowered by stock analysts at Needham & Company LLC from $48.00 to $46.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a 'buy' rating on the…
Swiss chikungunya fever patients live in close proximity
It is possible that two of the four patients were infected by the same mosquito, the Ticino cantonal medical officer stated in response to an enquiry from the Keystone-SDA news agency. The others were most likely bitten by related mosquitoes.
Revolution Medicines Q3 Earnings: Stellar Company And Drug, But The Market Knows It (RVMD)
Revolution Medicines delivered $198M in Q3 revenue from RASONQUE's five-week U.S. launch, treating over 5,000 patients post-FDA approval. Despite strong early sales, RVMD's $40B valuation and high expectations temper further upside until sustained…
Moderna to report Q3 amid valuation debate, cancer vaccine results: What to expect (MRNA:NASDAQ)
Moderna (MRNA) will report its third-quarter earnings on November 5, after the closing bell, amid heated discussions around the firm's valuation and the release of the much-discussed cancer vaccine results. Wall Street expects the pharma giant to…
Russia still hooked on Western firms for vital medicines
About 56% of the almost 700 billion rubles ($8.6 billion) spent on drugs in the first eight months of 2026 went on imports, particularly of the more sophisticated medicines domestic manufacturers are unable to replicate, according to Bloomberg…
Emerson Electric: LNG And Reshoring Tailwinds Justify Buying Despite A Rich Multiple (EMR)
Emerson Electric is positioned for durable, margin-accretive growth driven by industrial reshoring and global energy expansion. EMR's improving margin profile, strong cash generation, and shareholder returns through buybacks and dividends enhance…
Receive a Daily briefing on Pharma Industry News
Get Started